SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
January 18, 2017
Date of Report (Date of earliest event reported)
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.
445 NE 12th Ave. Fort Lauderdale, Florida
(Address of principal executive offices)
Registrants telephone number, including area code 516-205-4751
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
1.02 Termination of a Material Definitive Agreement
On April 18, 2017, WRAPmail, Inc (“WRAP”) terminated its joint venture agreement (the “Agreement”) with Health Max Group, Inc. (“Health Max”), which Agreement was disclosed in the Company’s current report filed January 17, 2017. The termination was by mutual agreement of the parties following the Company’s termination of its acquisition of Health Max.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: April 21, 2017
___/s/ Marco Alfonsi________
Marco Alfonsi, CEO